Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Predatory Publishing: Know the Difference Between a Financial Scheme and Scholarly Dissemination

Carina Stanton  |  Issue: December 2017  |  December 20, 2017

It happens every day. A new email pops up in a researcher’s in-box from a journal with a seemingly familiar name and an invitation to publish a research paper, present at a meeting or, perhaps, serve on an editorial board.

Dr. Hannan

Dr. Hannan

Like many of her colleagues, Marian Hannan, DSc, MPH, professor of medicine at Harvard Medical School and editor in chief of the ACR’s journal, Arthritis Care & Research, receives such email solicitations at least once per week and promptly sends them to her virtual trash bin.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The messages are usually effusively complimentary, with such introductions as ‘It is our extreme pleasure to invite you …,’” Dr. Hannan says, calling these messages phishing scams. “They also typically have misspellings and incorrect grammar, things you just wouldn’t see in any correspondence from a reputable publisher.”

Recognize the Scam

The term predatory publishing was coined by a librarian at the University of Colorado who maintained a website and blog (that have since been deactivated) providing critical analysis of open-access publishers that met the criteria of being predatory. These publications often have a scholarly sounding title that can be very similar (in name only) to respected journals. The scheme is generally the same: receive an invitation from an unknown editor or editorial assistant to publish an article online with little or no peer review or editing and often with a fee for publication that is often sent after the author provides their research for publication. Variations of this scheme continue to pop up, all targeting scholarly researchers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Predatory publishing itself has become the subject of scholarly investigation. Earlier this year, a well-known study, published in Nature and discussed in other publications including The New Yorker, invented a fake scientist who applied to serve on the editorial boards of 360 journals, including indexed journals with official impact factors, as well as journals suspected to be predatory. The researchers found that the journals deemed predatory were more likely to accept the fake scientist on their editorial boards.

Acknowledging the reality of predatory publishing is not a new trend. In 2005, a group of MIT students created a program, called SCIgen, to create “nonsensical computer-science papers with realistic-looking graphs, figures and citations” in response to their frustrations with predatory publishing practices. One notable fake article from the program was published, illustrating their point.1

So why, more than a decade after open discussions have emerged within academia about these predatory publishers, are they still out there?

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Professional TopicsTechnology Tagged with:CareerjournalonlinephysicianPractice ManagementpredatorypublishingrheumatologistrheumatologyscamsolicitationTechnology

Related Articles

    The Third Choice: The Predatory Journal Scam

    February 13, 2020

    “Greetings of the day!” My email account used to be flooded by these cheerful salutations, referring to me as an esteemed colleague or a thought leader. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEI have to admit: at first, I enjoyed receiving these messages. Normally, when I log into my email account, I’m greeted by messages—punctuated by red,…

    Summer 2021’s Awards, Appointments & Announcements in Rheumatology

    September 14, 2021

    Marian Hannan Celebrated after 10 Years as AC&R Editor-in-Chief By Kelly April Tyrrell This summer, the 10-year tenure of Marian Hannan, MPH, DSc, as editor in chief of Arthritis Care & Research (AC&R), has come to an end. Kelli Allen, PhD, assumed the post on July 1. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUE“Marian has done a…

    Lost and found

    A Look Back at the First Use of Cortisone in Rheumatoid Arthritis

    January 17, 2023

    In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…

    Thick Skin & Solid Research: Necessary Ingredients for Publishing Success

    June 1, 2023

    Scientific publishing requires a commitment to clear writing, concise narratives and a willingness to accept feedback. Daniel Solomon, MD, editor-in-chief of Arthritis & Rheumatology, provides insights into his experiences.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences